CD105 (Endoglin) expression in breast carcinoma effusions is a marker of poor survival
To access this article, please choose from the options below
PII: S0960-9776(10)00145-1
doi:10.1016/j.breast.2010.05.013
© 2010 Elsevier Ltd. All rights reserved.
PII: S0960-9776(10)00145-1
doi:10.1016/j.breast.2010.05.013
© 2010 Elsevier Ltd. All rights reserved.